Reach More Patients Faster

Real-World Evidence. Captured at the Source.

Climedo is the leading all-in-one platform for eCOA and EDC in real-world and late-phase studies. With Autonomous Data Capture (ADC), study data flows in directly at the source, with near-zero manual entry.

2+ M Patients

EU-Based & GDPR-First

Developed with Clinicians

The ADC Advantage: From Source to EDC, Without Re-Typing

Autonomous Data Capture flows source data into your EDC in three stages, with near-zero manual entry: less typing for sites, fewer queries and more time for patients.

  1. Stage 1

    Source Capture

    Data originates without manual entry.

    • Voice entry
    • PDF upload and scan
    • Photo capture via smartphone
    • EHR integration
  2. Stage 2

    AI Extraction

    AI structures the unstructured.

    • Data mapping
    • Confidence score
    • 4 eye principle
    • Unit conversion
    • Any-language input
  3. Stage 3

    Filled eCRF

    Human-approved import, with the groundwork done by AI.

    • GCP-compliant
    • Full audit trail
    • 21 CFR Part 11
Discharge summary CARDIOLOGY · UNIVERSITY HOSPITAL
04.09.2026
SUBJECT004-017 BORN1961 VISIT2 PAGE1 / 4

DIAGNOSIS

Type 2 diabetes mellitus, ICD-10 E11.9

MEDICATION ON DISCHARGE

Metformin1000 mg BID
Ramipril5 mg QD
Atorvastatin20 mg QD

LABORATORY

HbA1c7.2 %
Creatinine0.9 mg/dL
LDL cholesterol128 mg/dL

VITAL SIGNS

Blood pressure138 / 86 mmHg
Heart rate74 bpm
PD DR. MED. A. KELLER
SIGNED
04.09.2026
DXE11.9 · Type 2 diabetes
LABHbA1c 7.2 %
CONMEDMetformin 1000 mg
VITAL138 / 86 mmHg
Smart Import
Source document
AUTOMATED UNIT CONVERSION
LDL128 mg/dL→3.31 mmol/L
Creatinine0.9 mg/dL→79.6 µmol/L
Every value read in place, next to its source.
Result: near-zero manual data entry. Less site burden, faster study timelines, better data quality.

Launch in Days, Not Months

3 to 5 days to launch, versus 2 to 3 weeks with legacy EDC.

Protocol-to-Study: the AI Study Configurator visualizes your protocol, turns it into study specs and generates the study, from eCRFs, visits, randomization and ePRO to edit checks, queries and SAE forms, with your team approving each step. What traditionally takes weeks now takes days, from protocol upload to live study.

From Data to Dialogue

Instead of a static report years after study start, Climedo can deliver eCOA and ePRO data from observational studies in interactive dashboards while the study is still running. Participating physicians can follow the change in their patients’ study endpoint live and compare it in benchmarking: their own patients against all study participants, against individual treatment arms or, for example, against different regions based on the German Associations of Statutory Health Insurance Physicians (KV regions).

Benchmarking

Compare an individual patient against the study population. Select the patient, filter by criteria such as cohort, KV region or site type, and see where they sit in the histogram for a given visit, so treatment duration stays comparable.

Progression

Follow a patient’s selected parameter across site visits and detect outliers or changes in medical parameters at an early stage. Descriptive while the study runs, never a prescribing aid.

Industries

Built for Your Kind of Research

%

Customer Recommendation

~

Sites

+

Projects

Climedo Users

+ M

Patients

+%

Patient Adherence

The integratedAI-nativeEDC platform Hybrid Trials eConsent &Televisits

Clinical Trials and Surveys

Our Solutions for Your Clinical Data Capture

Capture study data straight from the source with Autonomous Data Capture (ADC), plus EDC, eCRF, ePRO and eSurveys, for real-world evidence with near-zero manual entry.

More About the Climedo Platform

EU-Based & GDPR-First

Data Hosting That Meets Your Compliance Needs.

All servers are in Frankfurt (AWS region): for EU studies, no data is processed outside the EU; US hosting is possible on request. Your study data sits with an ISO 27001-certified hosting partner, with strong data separation and state-of-the-art encryption, reviewed at federal level by the BSI and the BfDI. The Climedo system is auditable against ICH GCP, GAMP5 and FDA 21 CFR Part 11, so sponsors in the EU and the US can run studies on one platform without a compliance workaround.

Germany
Successful Data Capture for a Phase IV Study with ePRO solutions

Successful Data Capture for a Phase IV Study With ePRO Solutions

Read Case Study

Digital Health Bites

Go to our Blog Arrow Right Mini